VEGFR-3 fusion proteins

Forskningsoutput: PatentVetenskaplig

Sammanfattning

The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.
Originalspråkengelska
Utgivningsår9 sep 2008
StatusPublicerad - 9 sep 2008
MoE-publikationstypH1 Beviljat patent

Citera det här

Alitalo, K. K., & Jeltsch, M. M. (2008). VEGFR-3 fusion proteins. (Patentnr. US 7,422,741 B2). US Patent and Trademark Office.
Alitalo, Kari Kustaa (Författare) ; Jeltsch, Markku Michael (Författare). / VEGFR-3 fusion proteins. US Patent and Trademark Office. Patentnr.: US 7,422,741 B2. sep 09, 2008.
@misc{e93676bb1ff34696bf5567c6cf2547d5,
title = "VEGFR-3 fusion proteins",
abstract = "The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.",
author = "Alitalo, {Kari Kustaa} and Jeltsch, {Markku Michael}",
year = "2008",
month = "9",
day = "9",
language = "English",
publisher = "US Patent and Trademark Office",
address = "United States",
type = "Patent",
note = "US 7,422,741 B2",

}

Alitalo, KK & Jeltsch, MM sep. 09 2008, VEGFR-3 fusion proteins, Patentnr. US 7,422,741 B2.

VEGFR-3 fusion proteins. / Alitalo, Kari Kustaa; Jeltsch, Markku Michael.

US Patent and Trademark Office. Patentnr.: US 7,422,741 B2. sep 09, 2008.

Forskningsoutput: PatentVetenskaplig

TY - PAT

T1 - VEGFR-3 fusion proteins

AU - Alitalo, Kari Kustaa

AU - Jeltsch, Markku Michael

PY - 2008/9/9

Y1 - 2008/9/9

N2 - The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.

AB - The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.

M3 - Patent

M1 - US 7,422,741 B2

Y2 - 2008/09/09

PB - US Patent and Trademark Office

ER -

Alitalo KK, Jeltsch MM. VEGFR-3 fusion proteins. US 7,422,741 B2. 2008 sep 9.